한글목차

세계의 약제 남용 POCT(Point-of-Care Testing) 시장의 미래는 병원, 진단 센터, 재활 센터, 직장 검사 시설, 가정용 검사 키트 시장에서의 기회로 유망시되고 있습니다. 세계의 약제 남용 POCT 시장은 2025-2031년에 CAGR 9.0%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 예방적 건강관리 대책에 대한 관심이 높아지고, 휴대가 가능하고 사용자 친화적인 검사 장비의 개발이 진행되고 있다는 점입니다.

• Lucintel의 예측에 따르면 유형별로는 콜로이드 금 기반 시장이 예측 기간 중 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 병원이 가장 높은 성장이 예상되고 있습니다.
• 지역별로는 아시아태평양이 예측 기간 중 가장 높은 성장을 보일 것으로 예측됩니다.

약물 남용 POCT 시장의 새로운 동향

약물 남용 POCT 시장은 기술 혁신과 시장 수요의 변화로 인해 빠르게 발전하고 있습니다. 전 세계에서 약물 남용과의 싸움이 치열해지면서 보다 신속하고 정확하며 비용 효율적인 검사 방법에 대한 수요가 증가하고 있습니다. 다음은 시장을 형성하고 있는 5가지 주요 동향입니다.

• 멀티플렉스 검사 장비: 하나의 시료로 여러 물질을 검출할 수 있는 멀티플렉스 검사 장비가 약물남용 POCT 시장에서 인기를 끌고 있습니다. 이 장치를 통해 의료 서비스 프로바이더, 고용주, 법 집행 기관은 다양한 약물을 동시에 검사할 수 있으며, 검사 효율을 높일 수 있습니다. 여러 검사를 따로따로 수행해야 하는 비용과 시간을 줄이고, 결과의 정확성을 향상시키는 데 도움이 됩니다. 멀티플렉스 디바이스가 더욱 정교해짐에 따라 다양한 부문에서 신속한 약물 검사에 적합한 솔루션이 될 것으로 예측됩니다.
• 디지털 헬스 플랫폼과의 통합: 약물남용 POCT 기기는 디지털 헬스 플랫폼과의 통합이 진행되고 있으며, 실시간 데이터 수집, 모니터링, 보고가 가능해졌습니다. 이러한 플랫폼을 통해 의료 서비스 프로바이더와 고용주는 검사 결과를 원격으로 추적하고 개인의 약물 사용을 장기적으로 모니터링할 수 있습니다. 이러한 통합은 지속적인 모니터링이 용이하고 보다 맞춤 치료 계획을 수립할 수 있으므로 중독 회복 프로그램에 특히 유용합니다. 또한 환자와 의료 서비스 프로바이더 간의 커뮤니케이션이 개선되어 약물 남용 관리 프로그램의 전반적인 효과가 향상되었습니다.
• 재택 검사 키트: 재택 검사 키트는 약물 남용 POCT 시장에서 특히 재활 중인 환자 및 치료 순응도를 모니터링하기 위해 증가하는 추세입니다. 이 키트는 환자에게 프라이버시, 편의성, 사용 편의성을 제공하며, 집에서 편안하게 약물 검사를 할 수 있게 해줍니다. 약물 남용 모니터링이 장기적인 치료 프로그램에 필수적인 요소로 자리 잡으면서, 재택 검사 솔루션은 의료시설에 쉽게 접근할 수 없는 환자들에게 유용한 툴이 될 수 있습니다. 또한 이 키트는 회복 과정을 관리하는 환자에게 보다 유연하고 자율적인 회복 과정을 제공합니다.
• 비침습적 검사법: 타액, 땀, 호흡 분석과 같은 비침습적 검사법으로의 전환은 약물 남용 POCT 시장의 중요한 동향입니다. 이러한 검사법은 기존의 소변 검사나 혈액 검사에 비해 편의성 향상, 프라이버시 우려 감소, 빠른 결과 등 몇 가지 장점이 있습니다. 비침습적 검사는 빈번한 무작위 검사가 필요한 직장, 학교, 법 집행 기관에서 특히 유용합니다. 기술이 발전함에 따라 비침습적 검사법은 신뢰성이 높아져 일상적인 약물 남용 모니터링의 일부로 널리 받아들여질 것으로 예측됩니다.
• 모바일 및 휴대용 검사 솔루션: 모바일 및 휴대용 검사 솔루션은 약물 검사를 보다 친숙하고 유연하게 만들어 POCT 시장을 변화시키고 있습니다. 어디서나 검사할 수 있는 이 장비는 의료시설에 대한 접근이 제한되어 있는 오지나 의료 서비스가 부족한 지역에서 특히 유용하게 사용할 수 있습니다. 모바일 검사 장비는 실시간으로 빠른 결과를 제공하므로 법 집행 기관이나 직장내 검사에도 유용합니다. 사용하기 쉽고 휴대가 간편하며, 더 작고 컴팩트한 장비의 개발로 POCT의 활용 범위가 확대되어 약물 남용 모니터링이 언제 어디서나 이루어질 수 있게 되었습니다.

멀티플렉스 검사 장비, 디지털 헬스 통합, 가정용 검사 키트, 비침습적 검사법, 모바일 솔루션 등 새로운 동향이 약물 남용 POCT 시장을 변화시키고 있습니다. 이러한 추세는 검사의 접근성, 효율성, 정확성을 높여 약물 남용 관리 및 회복 모니터링을 개선할 수 있습니다. 이러한 동향이 계속 발전함에 따라 약물 검사의 미래가 형성되고, 전 세계 개인과 지역사회의 결과가 개선될 것으로 예측됩니다.

약물 남용 POCT 시장의 최근 동향

약물 남용 POCT 시장의 최근 동향은 기술의 발전, 약물 남용 증가, 보다 효율적인 검사 솔루션의 필요성이 대두되고 있습니다. 이러한 발전으로 인해 의료, 직장, 법 집행 기관에서 약물 검사에 대한 상황이 완전히 바뀌고 있습니다. 다음은 시장을 재편하고 있는 최근 주요 5가지 동향입니다.

• 신속 다약제 검사 도입: 신속 다약제 병용 검사는 POCT 시장에서 주요한 발전이 되고 있습니다. 이 검사는 한 번의 샘플로 다양한 물질을 검출할 수 있으며, 의료 서비스 프로바이더, 고용주, 법 집행 기관이 보다 빠르고 효율적인 결과를 얻을 수 있습니다. 각 물질에 대해 개별적으로 검사하는 데 소요되는 시간과 비용을 절감함으로써, 다약제 병용 검사는 다양한 환경에서 약물 검사 프로세스를 간소화할 수 있습니다. 이 개발은 여러 약물 사용 문제가 있는 환자 모니터링에 중점을 둔 프로그램과 직장 안전 개선에 필수적입니다.
• 실시간 모니터링을 위한 디지털 통합의 발전: 최근 디지털 기술의 발전으로 POCT 장비와 디지털 플랫폼과의 통합이 용이해져 실시간 모니터링 및 보고가 가능해졌습니다. 의료 서비스 프로바이더와 고용주는 약물 검사 결과를 즉시 추적할 수 있게 되어 약물 남용 사례에 대한 신속한 개입과 더 나은 관리를 보장할 수 있게 되었습니다. 이 개발은 약물 사용을 장기적으로 모니터링하는 것이 중요한 중독 치료 프로그램에서 특히 유용합니다. 또한 보다 정확하고 시기적절한 의사결정을 보장함으로써 직장내 약물 검사 프로그램을 강화할 수 있습니다.
• 비침습적 검사 기술의 성장: 타액, 땀, 호흡 분석과 같은 비침습적 검사법은 POCT 시장에서 큰 진전을 이루고 있습니다. 이러한 방법은 침습성이 낮고 환자에게 편리하므로 학교, 직장, 의료 환경에서 사용하기에 적합합니다. 비침습적 검사는 또한 법 집행 기관이 거리에서 마약 검사에 채택하여 그 활용을 더욱 확대하고 있습니다. 이러한 기술이 발전함에 따라 특히 빈번한 검사나 무작위 검사가 필요한 환경에서는 신뢰성이 높아져 널리 수용될 것으로 예측됩니다.
• 검사 장비의 정확도와 민감도 향상: 최근 약물남용 POCT 장비의 발전은 검사의 정확도와 민감도 향상에 초점을 맞추었습니다. 여기에는 오피오이드의 확산으로 심각한 우려를 낳고 있는 펜타닐과 같은 체내 저농도 물질에 대한 보다 정확한 검출 방법의 개발도 포함됩니다. 이러한 기술 혁신은 검사의 신뢰성을 높여 위양성 및 위음성을 줄이고 검사 결과의 정확성과 신뢰성을 보장하는 데 도움이 됩니다. 정확도 향상은 중독 치료, 작업장 약물 검사 및 법 집행 상황 모니터링에 매우 중요합니다.
• 검사기기의 신속한 승인에 대한 규제당국의 지원: 규제기관은 약물 오남용에 대한 POCT 기기의 신속한 승인에 대한 지원을 강화하고 있습니다. 이를 통해 새롭고 개선된 검사 솔루션이 더 빨리 시장에 출시될 수 있게 되었습니다. 예를 들어 여러 약물을 동시에 감지할 수 있는 기기는 규제 당국의 승인을 더 빨리 받아 의료 서비스 프로바이더, 고용주 및 법 집행 기관이 증가하는 약물 남용 문제에 대처하는 데 필요한 툴을 사용할 수 있게 되었습니다. 이러한 규제 변화는 POCT 시장의 기술 혁신을 촉진하고 있습니다.

다약제 병용 검사, 디지털 통합, 비침습적 검사, 정확도 향상, 규제 지원 등 약물 남용 POCT 시장의 최근 동향은 약물 검사 상황에 혁명을 일으키고 있습니다. 이러한 발전은 검사의 속도, 정확성, 접근성을 향상시켜 의료, 직장, 법 집행 기관 등 모든 분야에서 약물 남용 관리를 개선하는 데 필수적인 요소로 작용하고 있습니다. 이러한 개발이 진행됨에 따라 약물 남용의 확산과 싸우는 데 중요한 역할을 할 수 있을 것으로 보입니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 산업 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 약물남용 POCT 시장(유형별)

• 개요
• 유형별 매력 분석
• 콜로이드금 기반 : 동향과 예측(2019-2031년)
• 형광 면역 크로마토그래피 기반 : 동향과 예측(2019-2031년)

제5장 세계의 약물남용 POCT 시장(용도별)

• 개요
• 용도별 매력 분석
• 병원 : 동향과 예측(2019-2031년)
• 진단 센터 : 동향과 예측(2019-2031년)
• 재활 센터 : 동향과 예측(2019-2031년)
• 직장 검사 시설 : 동향과 예측(2019-2031년)
• 가정용 검사 키트 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 지역별 : 세계의 약물남용 POCT 시장

제7장 북미의 약물남용 POCT 시장

• 개요
• 북미의 약물남용 POCT 시장(유형별)
• 북미의 약물남용 POCT 시장(용도별)
• 미국의 약물남용 POCT 시장
• 멕시코의 약물남용 POCT 시장
• 캐나다의 약물남용 POCT 시장

제8장 유럽의 약물남용 POCT 시장

• 개요
• 유럽의 약물남용 POCT 시장(유형별)
• 유럽의 약물남용 POCT 시장(용도별)
• 독일의 약물남용 POCT 시장
• 프랑스의 약물남용 POCT 시장
• 스페인의 약물남용 POCT 시장
• 이탈리아의 약물남용 POCT 시장
• 영국의 약물남용 POCT 시장

제9장 아시아태평양의 약물남용 POCT 시장

• 개요
• 아시아태평양의 약물남용 POCT 시장(유형별)
• 아시아태평양의 약물남용 POCT 시장(용도별)
• 일본의 약물남용 POCT 시장
• 인도의 약물남용 POCT 시장
• 중국의 약물남용 POCT 시장
• 한국의 약물남용 POCT 시장
• 인도네시아의 약물남용 POCT 시장

제10장 기타 지역의 약물남용 POCT 시장

• 개요
• 기타 지역의 약물남용 POCT 시장(유형별)
• 기타 지역의 약물남용 POCT 시장(용도별)
• 중동의 지역의 약물남용 POCT 시장
• 남미의 지역의 약물남용 POCT 시장
• 아프리카의 지역의 약물남용 POCT 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 약물남용 POCT 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증과 라이선싱
  • 합병, 인수, 계약, 제휴, 합병사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

• 경쟁 분석
• Roche
• Danaher
• Abbott
• Siemens
• Beijing Hotgen BIoTech
• Hangzhou BIoTest BIoTech Co.
• Assure Tech
• Orient Gene
• Thermo Fisher

제14장 부록

• 도표
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel 소개
• 문의처

영문목차

The future of the global point-of-care testing (POCT) for substance abuse market looks promising with opportunities in the hospital, diagnostic center, rehabilitation centers, workplace testing facilities, and home testing kits markets. The global point-of-care testing (POCT) for substance abuse market is expected to grow with a CAGR of 9.0% from 2025 to 2031. The major drivers for this market are the rising focus on preventive healthcare measures and the increasing development of portable and user-friendly testing devices.

• Lucintel forecasts that, within the type category, based on colloidal gold is expected to witness higher growth over the forecast period.
• Within the application category, the hospital is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is evolving rapidly, driven by technological innovations and changing market needs. The demand for faster, more accurate, and cost-effective testing methods is growing as the global fight against substance abuse intensifies. Here are five key trends reshaping the market.

• Multiplex Testing Devices: Multiplex testing devices that can detect multiple substances in a single sample are gaining popularity in the POCT market for substance abuse. These devices allow healthcare providers, employers, and law enforcement to test for a range of drugs simultaneously, making testing more efficient. They help reduce the cost and time associated with performing multiple separate tests and improve the accuracy of results. As multiplex devices become more sophisticated, they are expected to become the preferred solution for rapid drug testing across various sectors.
• Integration with Digital Health Platforms: POCT devices for substance abuse are increasingly being integrated with digital health platforms, enabling real-time data collection, monitoring, and reporting. These platforms allow healthcare providers and employers to track test results remotely and monitor individuals' substance use over time. This integration is particularly beneficial for addiction recovery programs, as it facilitates continuous monitoring and allows for more personalized treatment plans. It also improves communication between patients and healthcare providers, enhancing the overall effectiveness of drug abuse management programs.
• At-Home Testing Kits: At-home testing kits are becoming a growing trend in the POCT market for substance abuse, particularly for individuals undergoing rehabilitation or monitoring treatment adherence. These kits provide privacy, convenience, and ease of use for patients, allowing them to test for drugs in the comfort of their homes. As substance abuse monitoring becomes a more integral part of long-term treatment programs, at-home testing solutions offer a valuable tool for individuals who may not have easy access to medical facilities. These kits also offer more flexibility and autonomy for patients managing their recovery process.
• Non-Invasive Testing Methods: The shift towards non-invasive testing methods such as saliva, sweat, and breath analysis is an important trend in the POCT market for substance abuse. These methods offer several advantages over traditional urine and blood testing, including increased comfort, reduced privacy concerns, and faster results. Non-invasive testing is particularly useful in workplaces, schools, and law enforcement settings where frequent, random testing is needed. As the technology improves, non-invasive methods are expected to become more reliable and widely accepted as part of routine substance abuse monitoring.
• Mobile and Portable Testing Solutions: Mobile and portable testing solutions are transforming the POCT market by making drug testing more accessible and flexible. With the ability to test anywhere, these devices are particularly useful in remote or underserved areas where access to healthcare facilities is limited. Mobile testing units are also beneficial for law enforcement and workplace testing, providing rapid results in real-time. The development of smaller, more compact devices that are easy to use and carry is expanding the reach of POCT, ensuring that substance abuse monitoring can take place anytime and anywhere.

Emerging trends such as multiplex testing devices, digital health integration, at-home testing kits, non-invasive testing methods, and mobile solutions are transforming the POCT market for substance abuse. These trends enhance the accessibility, efficiency, and accuracy of testing, enabling better substance abuse management and recovery monitoring. As these trends continue to evolve, they will shape the future of drug testing, improving outcomes for individuals and communities worldwide.

Recent Developments in the Point-of-Care Testing (POCT) for Substance Abuse Market

Recent developments in the Point-of-Care Testing (POCT) for substance abuse market have been driven by technological advancements, the rise in substance abuse, and the need for more efficient testing solutions. These developments are transforming the landscape of drug testing in healthcare, workplaces, and law enforcement. Below are five key recent developments that are reshaping the market.

• Introduction of Rapid, Multi-Drug Tests: Rapid, multi-drug tests have become a key development in the POCT market. These tests can detect various substances in a single sample, providing faster and more efficient results for healthcare providers, employers, and law enforcement agencies. By reducing the time and costs associated with running individual tests for each substance, multi-drug tests help streamline drug testing processes in a variety of settings. This development is essential for programs focused on monitoring patients with multiple substance use issues and for improving workplace safety.
• Advances in Digital Integration for Real-Time Monitoring: Recent advances in digital technology have facilitated the integration of POCT devices with digital platforms for real-time monitoring and reporting. Healthcare providers and employers can now track drug test results instantly, ensuring quicker intervention and better management of substance abuse cases. This development is particularly beneficial in addiction treatment programs, where monitoring drug use over time is critical. It also enhances workplace drug testing programs by ensuring more accurate and timely decision-making.
• Growth of Non-Invasive Testing Technologies: Non-invasive testing methods, such as saliva, sweat, and breath analysis, have made significant strides in the POCT market. These methods are less invasive and more convenient for patients, making them ideal for use in schools, workplaces, and healthcare settings. Non-invasive tests are also being adopted by law enforcement agencies for roadside drug testing, further expanding their use. As these technologies improve, they are expected to become more reliable and widely accepted, particularly in settings that require frequent or random testing.
• Improved Accuracy and Sensitivity of Testing Devices: Recent advancements in POCT devices for substance abuse have focused on improving the accuracy and sensitivity of tests. This includes the development of more precise detection methods for low levels of substances in the body, such as fentanyl, which is becoming a significant concern in the opioid epidemic. By increasing the reliability of testing, these innovations help reduce false positives and negatives, ensuring that results are accurate and trustworthy. Improved accuracy is crucial for addiction treatment and workplace drug testing, as well as for monitoring law enforcement situations.
• Regulatory Support for Expedited Approvals of Testing Devices: Regulatory bodies are providing more support for the expedited approval of POCT devices for substance abuse. This has led to the quicker availability of new and improved testing solutions in the market. For example, devices capable of detecting multiple drugs simultaneously have received faster regulatory approval, ensuring that healthcare providers, employers, and law enforcement agencies can access the tools they need to address the growing issue of substance abuse. This regulatory shift is driving innovation in the POCT market.

Recent developments in the POCT market for substance abuse, including multi-drug tests, digital integration, non-invasive testing, improved accuracy, and regulatory support, are revolutionizing the drug testing landscape. These advancements are improving the speed, accuracy, and accessibility of testing, which is essential for better substance abuse management across healthcare, workplace, and law enforcement settings. As these developments continue, they will play a significant role in combating the growing substance abuse epidemic.

Strategic Growth Opportunities in the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is expanding rapidly as more sectors look for efficient, accessible drug testing solutions. Key applications such as clinical diagnostics, workplace testing, and rehabilitation programs are creating growth opportunities for manufacturers. Here are five strategic growth opportunities within the POCT market for substance abuse.

• Clinical Diagnostics in Addiction Treatment: Clinical diagnostics in addiction treatment is a major growth opportunity for POCT. Rapid testing for drugs allows healthcare providers to quickly assess patient conditions and monitor treatment progress. With more addiction treatment centers adopting POCT to track drug use and recovery, this sector is expected to continue growing. The ability to test patients frequently for a range of substances also helps in preventing relapse and ensuring patients receive appropriate care.
• Workplace Testing for Drug Safety: Workplace drug testing is another key growth opportunity in the POCT market for substance abuse. Employers are increasingly adopting rapid drug testing solutions to ensure a safe and drug-free workplace. POCT devices that provide fast, reliable results are becoming essential for pre-employment screenings, random testing, and post-incident testing. The growing focus on workplace safety and productivity is driving the demand for these testing solutions.
• At-Home Drug Testing Kits for Treatment Monitoring: At-home drug testing kits for individuals undergoing treatment or recovery programs represent an emerging growth opportunity. These kits offer convenience and privacy, enabling patients to monitor their substance use at home. As drug addiction continues to be a major public health issue, offering patients affordable and accessible home testing solutions will help them stay engaged in their recovery and reduce relapse rates.
• Mobile Testing Units for Remote Areas: Mobile testing units for remote and underserved areas present a significant growth opportunity. These units allow for rapid testing in areas with limited access to healthcare facilities, improving drug abuse monitoring in rural areas. Mobile units are also helpful for law enforcement agencies and large employers who need on-site testing solutions. Expanding the reach of testing services into remote locations is critical for addressing the widespread nature of substance abuse.
• Telemedicine Integration for Remote Monitoring: Telemedicine integration for remote monitoring of substance abuse is gaining traction as a growth opportunity. By combining POCT devices with telemedicine platforms, healthcare providers can remotely monitor patients and receive instant test results. This offers a more flexible and accessible approach to managing substance use disorders, particularly for patients in rural or underserved regions. This integration allows for real-time interventions and personalized treatment plans, improving patient outcomes.

Strategic growth opportunities in the POCT market for substance abuse lie in clinical diagnostics, workplace testing, at-home drug testing, mobile units, and telemedicine integration. These applications enhance the accessibility, efficiency, and affordability of drug testing, allowing for more effective substance abuse management across healthcare, workplaces, and remote areas. By focusing on these opportunities, manufacturers can help meet the growing demand for rapid, accurate drug testing solutions.

Point-of-Care Testing (POCT) for Substance Abuse Market Driver and Challenges

The Point-of-Care Testing (POCT) for substance abuse market is influenced by various drivers and challenges that impact its growth. Technological innovations, the rising prevalence of substance abuse, and regulatory support are driving the market, while economic, regulatory, and technical challenges continue to pose obstacles. Understanding these factors is crucial for companies looking to succeed in this evolving market.

The factors responsible for driving the point-of-care testing (POCT) for substance abuse market include:

1. Technological Advancements: Technological innovations in POCT devices are a primary driver of market growth. Advances in multiplex testing, non-invasive testing methods, and integration with digital health platforms have increased the efficiency and accuracy of drug testing. These developments make POCT solutions more accessible, cost-effective, and reliable, driving adoption across healthcare, workplaces, and law enforcement settings. As technology continues to evolve, it is expected to further enhance the capabilities of POCT devices, expanding their applications and improving outcomes.

2. Rising Substance Abuse: The increasing prevalence of substance abuse, particularly opioids, is a major driver of the POCT market. As addiction rates continue to rise, the demand for fast and accurate drug testing solutions grows. POCT enables healthcare providers and law enforcement agencies to respond more quickly to substance use and intervene early. The opioid epidemic, in particular, has highlighted the need for rapid testing to detect drug abuse and prevent overdose deaths, making POCT solutions essential for public health efforts.

3. Workplace Safety and Compliance: Workplace safety regulations are driving the demand for POCT solutions. Employers are increasingly adopting drug testing to ensure a safe and productive work environment. Rapid, accurate testing allows employers to meet compliance requirements and manage risks related to substance abuse in the workplace. As more companies prioritize drug-free environments, the demand for POCT devices in this sector is expected to grow, particularly in industries with safety-sensitive roles.

4. Regulatory Support: Governments and regulatory bodies are providing support for the development and approval of POCT devices for substance abuse. Faster regulatory approvals and more streamlined processes are helping companies bring new products to market more quickly. This regulatory environment encourages innovation and investment in POCT technology, making it easier for manufacturers to develop and introduce advanced solutions. Regulatory support also helps establish standards for testing accuracy and reliability, ensuring consistent quality across the market.

5. Patient-Centric Healthcare Approach: The shift towards a more patient-centric healthcare approach, where patients take an active role in managing their health, is driving demand for at-home drug testing solutions. Patients with substance use disorders benefit from the ability to monitor their drug use and stay engaged in their recovery process. POCT devices that enable self-testing are becoming increasingly popular, especially in addiction treatment programs that prioritize patient autonomy and continuous care.

Challenges in the point-of-care testing (POCT) for substance abuse market are:

1. Regulatory Hurdles: Regulatory challenges remain a significant barrier to the growth of the POCT market for substance abuse. Different countries have varying regulations and approval processes for POCT devices, which can delay the introduction of new products. Manufacturers must navigate complex regulatory requirements to ensure compliance, which can increase development costs and time to market. These hurdles can be particularly challenging for smaller companies with limited resources.

2. High Development Costs: The development and production of POCT devices for substance abuse can be costly, particularly for advanced testing technologies that require specialized materials and components. High development costs can result in higher prices for end users, limiting access to testing solutions in low-income regions. Manufacturers must find ways to reduce production costs without compromising the quality and accuracy of the tests to ensure affordability and wider adoption.

3. Accuracy and Reliability Concerns: While POCT devices have made significant advancements, there are still concerns regarding the accuracy and reliability of certain tests. False positives or false negatives can undermine the effectiveness of POCT, leading to misdiagnosis or mismanagement of substance abuse. Manufacturers must continue to improve the precision of their testing devices and ensure that they meet rigorous performance standards to gain widespread acceptance in healthcare, workplace, and law enforcement settings.

The major drivers of the POCT market for substance abuse include technological advancements, rising substance abuse, workplace safety concerns, regulatory support, and a patient-centric healthcare approach. However, challenges such as regulatory hurdles, high development costs, and accuracy concerns still need to be addressed. By overcoming these obstacles, the POCT market for substance abuse can continue to grow and provide essential tools for addressing the global substance abuse crisis.

List of Point-of-Care Testing (POCT) Companies for Substance Abuse Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies point-of-care testing (POCT) companies for substance abuse market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the point-of-care testing (POCT) companies for substance abuse market are profiled in this report include-

• Roche
• Danaher
• Abbott
• Siemens
• Beijing Hotgen Biotech
• Hangzhou Biotest Biotech Co.
• Assure Tech
• Orient Gene
• Thermo Fisher

Point-of-Care Testing (POCT) for Substance Abuse Market by Segment

The study includes a forecast for the global point-of-care testing (POCT) for substance abuse market by type, application, and region.

Point-of-Care Testing (POCT) for Substance Abuse Market by Type [Value from 2019 to 2031]:

• Based on Colloidal Gold
• Based on Fluorescence Immunochromatography

Point-of-Care Testing (POCT) for Substance Abuse Market by Application [Value from 2019 to 2031]:

• Hospital
• Diagnostic Center
• Rehabilitation Centers
• Workplace Testing Facilities
• Home Testing Kits

Point-of-Care Testing (POCT) for Substance Abuse Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is growing rapidly due to the increasing need for fast, accessible, and accurate drug testing solutions. POCT allows for the immediate detection of substances like opioids, cocaine, marijuana, and alcohol in various settings such as healthcare facilities, workplaces, and law enforcement. With the rise of substance abuse, especially opioid-related issues, countries like the United States, China, Germany, India, and Japan are increasingly adopting these technologies. In these countries, POCT is becoming a crucial tool for addressing addiction, ensuring workplace safety, and monitoring patients' substance use, reflecting key advancements in testing technologies.

• United States: In the United States, the POCT market for substance abuse has expanded significantly due to the growing opioid crisis and a rising need for rapid drug testing in healthcare and workplace environments. Recent developments include more advanced urine, saliva, and hair follicle tests for a broader range of substances. There has been a push towards integrating digital solutions with POCT devices to streamline reporting and monitoring. Furthermore, the FDA has approved new POCT devices capable of detecting multiple drugs simultaneously, improving efficiency and accessibility. These developments are aimed at enhancing patient care and helping with drug monitoring programs.
• China: The Chinese POCT market for substance abuse is also expanding as part of a broader effort to combat drug-related issues. The country has witnessed a rise in POCT devices capable of detecting substances like methamphetamine, heroin, and opiates, which is especially relevant as the government works to control the abuse of illegal drugs. Local manufacturers are developing affordable and accessible testing solutions tailored to meet the needs of public health systems, police forces, and businesses. China is also increasing its focus on integrating POCT technology into routine healthcare, contributing to better monitoring of individuals undergoing rehabilitation for drug addiction.
• Germany: Germany has seen notable advancements in the POCT market for substance abuse due to stricter regulations and a growing awareness of addiction issues. Germany's healthcare system is increasingly adopting POCT for detecting drugs in patients with addiction disorders and in workplace environments. Recently, the development of more accurate and sensitive testing devices for opioids and other common illicit drugs has been a key trend. There is also a push towards better integration with digital health platforms to improve the monitoring of treatment adherence and drug rehabilitation outcomes. These developments are driving the adoption of POCT technology across public health and law enforcement sectors.
• India: In India, the POCT market for substance abuse is emerging due to the increasing need for rapid drug testing in various sectors, including healthcare, law enforcement, and the workplace. Recent developments include the introduction of affordable and portable drug testing kits that are especially beneficial in rural areas with limited access to traditional laboratory facilities. India's push to address rising substance abuse and addiction problems has led to government initiatives supporting the use of POCT devices in public health campaigns. These efforts are also coupled with the growth of telemedicine, facilitating remote testing and consultation, which enhances accessibility for patients in remote areas.
• Japan: Japan is witnessing growth in the POCT market for substance abuse, driven by rising concerns about drug use among the younger population. Recent advancements include the development of highly accurate tests for a wide range of substances, including amphetamines, narcotics, and cannabis. Japan's regulatory framework supports the use of POCT in workplaces and law enforcement, with a focus on non-invasive testing methods like saliva and sweat testing. Additionally, innovations in mobile testing units and the integration of POCT with digital health platforms for real-time monitoring are further accelerating the adoption of substance abuse testing solutions in the country.

Features of the Global Point-of-Care Testing (POCT) for Substance Abuse Market

• Market Size Estimates: Point-of-care testing (POCT) for substance abuse market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Point-of-care testing (POCT) for substance abuse market size by type, application, and region in terms of value ($B).
• Regional Analysis: Point-of-care testing (POCT) for substance abuse market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the point-of-care testing (POCT) for substance abuse market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the point-of-care testing (POCT) for substance abuse market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the point-of-care testing (POCT) for substance abuse market by type (based on colloidal gold and based on fluorescence immunochromatography), application (hospital, diagnostic center, rehabilitation centers, workplace testing facilities, and home testing kits), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Based on Colloidal Gold: Trends and Forecast (2019-2031)
• 4.4 Based on Fluorescence Immunochromatography: Trends and Forecast (2019-2031)

5. Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Diagnostic Center: Trends and Forecast (2019-2031)
• 5.5 Rehabilitation Centers: Trends and Forecast (2019-2031)
• 5.6 Workplace Testing Facilities: Trends and Forecast (2019-2031)
• 5.7 Home Testing Kits: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Point-of-Care Testing (POCT) for Substance Abuse Market by Region

7. North American Point-of-Care Testing (POCT) for Substance Abuse Market

• 7.1 Overview
• 7.2 North American Point-of-Care Testing (POCT) for Substance Abuse Market by Type
• 7.3 North American Point-of-Care Testing (POCT) for Substance Abuse Market by Application
• 7.4 United States Point-of-Care Testing (POCT) for Substance Abuse Market
• 7.5 Mexican Point-of-Care Testing (POCT) for Substance Abuse Market
• 7.6 Canadian Point-of-Care Testing (POCT) for Substance Abuse Market

8. European Point-of-Care Testing (POCT) for Substance Abuse Market

• 8.1 Overview
• 8.2 European Point-of-Care Testing (POCT) for Substance Abuse Market by Type
• 8.3 European Point-of-Care Testing (POCT) for Substance Abuse Market by Application
• 8.4 German Point-of-Care Testing (POCT) for Substance Abuse Market
• 8.5 French Point-of-Care Testing (POCT) for Substance Abuse Market
• 8.6 Spanish Point-of-Care Testing (POCT) for Substance Abuse Market
• 8.7 Italian Point-of-Care Testing (POCT) for Substance Abuse Market
• 8.8 United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market

9. APAC Point-of-Care Testing (POCT) for Substance Abuse Market

• 9.1 Overview
• 9.2 APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Type
• 9.3 APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Application
• 9.4 Japanese Point-of-Care Testing (POCT) for Substance Abuse Market
• 9.5 Indian Point-of-Care Testing (POCT) for Substance Abuse Market
• 9.6 Chinese Point-of-Care Testing (POCT) for Substance Abuse Market
• 9.7 South Korean Point-of-Care Testing (POCT) for Substance Abuse Market
• 9.8 Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market

10. ROW Point-of-Care Testing (POCT) for Substance Abuse Market

• 10.1 Overview
• 10.2 ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Type
• 10.3 ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Application
• 10.4 Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market
• 10.5 South American Point-of-Care Testing (POCT) for Substance Abuse Market
• 10.6 African Point-of-Care Testing (POCT) for Substance Abuse Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Point-of-Care Testing (POCT) for Substance Abuse Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Roche
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Danaher
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Abbott
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Siemens
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Beijing Hotgen Biotech
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Hangzhou Biotest Biotech Co.
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Assure Tech
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Orient Gene
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Thermo Fisher
  • Company Overview
  • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us